A private researcher investigating the history of the U.S. biological weapons program at the National Archives recently came up empty.
“She asked for the files for Fort Detrick from 1946 to 1956, and was brought 16 cartons,” recounted Milton Leitenberg of the University of Maryland. “However, every single file in every one of the 16 cartons had been removed, and replaced with a page dated post-2002, saying that the item had been withdrawn.”
The Fort Detrick records were removed from public access “after the Bush administration ordered agencies to withhold anything that might aid terrorists,” reported Scott Shane, then of the Baltimore Sun, in an August 1, 2004 Sun story on Fort Detrick’s Special Operations Division.
Meanwhile, the record of a congressional hearing that was held last year on biological terrorism has just been published.
See “Engineering Bio-Terror Agents: Lessons from the Offensive U.S. and Soviet Biological Weapons Programs,” House Committee on Homeland Security, July 13, 2005.
Coordination among federal science agencies is essential to ensure government-wide alignment on R&D investment priorities. However, the federal R&D enterprise suffers from egregious siloization.
Don’t like the Chinese-backed EVs that are undercutting your market? Start with a well-designed statute to strengthen market oversight and competition while also providing American companies with support.
Cities and states are best positioned to design policies to accelerate clean energy, innovation, and economic development because they can design approaches that work in different social, political, and economic contexts.
Outcome-Based Contracting reframes procurement around the staged achievement of measurable mission outcomes rather than the delivery of predefined technical artifacts.